ZOETIS INC (ZOE.DE) Stock Price, Forecast & Analysis
Europe - FRA:ZOE - US98978V1035 - Common Stock
ZOE.DE Key Statistics, Chart & Performance
The current stock price of ZOE.DE is 102.94 EUR. In the past month the price decreased by -15.61%. In the past year, price decreased by -37.19%.
ZOE.DE Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 1SAN.MI | SANOFI | 11.48 | 212.54B | ||
| SAN.PA | SANOFI | 11.24 | 208.13B | ||
| SNW.DE | SANOFI | 11.24 | 208.11B | ||
| 1MRK.MI | MERCK KGAA | 13.35 | 49.41B | ||
| MRK.DE | MERCK KGAA | 12.86 | 47.59B | ||
| UCB.BR | UCB SA | 35.31 | 44.10B | ||
| 1BAYN.MI | BAYER AG-REG | 5.28 | 26.00B | ||
| BAYN.DE | BAYER AG-REG | 5.2 | 25.60B | ||
| REC.MI | RECORDATI INDUSTRIA CHIMICA | 25.24 | 10.40B | ||
| IPN.PA | IPSEN | 12.05 | 10.38B | ||
| TUB.BR | FINANCIERE DE TUBIZE | 97.84 | 9.06B | ||
| VIRP.PA | VIRBAC SA | 19.9 | 2.89B |
Related stock screener links
About ZOE.DE
Company Profile
Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. The company is headquartered in Parsippany, New Jersey and currently employs 13,800 full-time employees. The company went IPO on 2013-02-01. The firm is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests and precision animal health. The firm operates through two segments: the United States (U.S.) and International. Within each of these operating segments, it offers a diversified product portfolio, including parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics, for both companion animal and livestock customers. The company directly markets its products in approximately 45 countries across North America, Europe, Africa, Asia, Australia and South America. The firm is engaged in commercializing products across eight species: dogs, cats and horses (collectively, companion animals) and cattle, poultry, swine, fish and sheep (collectively, livestock).
Company Info
ZOETIS INC
10 Sylvan Way
Parsippany NEW JERSEY US
Employees: 13800
Phone: 19738227000
ZOETIS INC / ZOE.DE FAQ
What does ZOE do?
Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. The company is headquartered in Parsippany, New Jersey and currently employs 13,800 full-time employees. The company went IPO on 2013-02-01. The firm is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests and precision animal health. The firm operates through two segments: the United States (U.S.) and International. Within each of these operating segments, it offers a diversified product portfolio, including parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics, for both companion animal and livestock customers. The company directly markets its products in approximately 45 countries across North America, Europe, Africa, Asia, Australia and South America. The firm is engaged in commercializing products across eight species: dogs, cats and horses (collectively, companion animals) and cattle, poultry, swine, fish and sheep (collectively, livestock).
What is the stock price of ZOETIS INC today?
The current stock price of ZOE.DE is 102.94 EUR. The price decreased by -1.02% in the last trading session.
Does ZOE stock pay dividends?
ZOETIS INC (ZOE.DE) has a dividend yield of 1.31%. The yearly dividend amount is currently 1.5.
What is the ChartMill technical and fundamental rating of ZOE stock?
ZOE.DE has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
What is the expected growth for ZOE stock?
The Revenue of ZOETIS INC (ZOE.DE) is expected to grow by 2.86% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
What is the market capitalization of ZOE stock?
ZOETIS INC (ZOE.DE) has a market capitalization of 45.62B EUR. This makes ZOE.DE a Large Cap stock.
Can you provide the upcoming earnings date for ZOETIS INC?
ZOETIS INC (ZOE.DE) will report earnings on 2026-02-11, after the market close.
ZOE.DE Technical Analysis
ZOE.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to ZOE.DE. While ZOE.DE belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health.
ZOE.DE Financial Highlights
Over the last trailing twelve months ZOE.DE reported a non-GAAP Earnings per Share(EPS) of 5.48. The EPS increased by 10.07% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 27.83% | ||
| ROA | 18.04% | ||
| ROE | 52.48% | ||
| Debt/Equity | 1.05 |
ZOE.DE Forecast & Estimates
24 analysts have analysed ZOE.DE and the average price target is 167.12 EUR. This implies a price increase of 62.35% is expected in the next year compared to the current price of 102.94.
For the next year, analysts expect an EPS growth of 8.38% and a revenue growth 2.86% for ZOE.DE